Sign in

You're signed outSign in or to get full access.

Anthony P. Takitani

Director at MAUI LAND & PINEAPPLE CO
Board

About Anthony P. Takitani

Anthony P. Takitani (age 70) is an independent director of Maui Land & Pineapple Company, Inc. (MLP), serving since April 2015. He is a partner at Takitani Agaran Jorgensen and Wildman LLP, specializing in real estate, commercial, and personal injury law, and previously served two terms in the Hawaii House of Representatives (1978–1982). He holds a JD from Southwestern University School of Law and a BA in Political Science from the University of Hawai‘i at Mānoa, bringing legal, legislative, and community experience to MLP’s board .

Past Roles

OrganizationRoleTenureCommittees/Impact
Takitani Agaran Jorgensen & Wildman LLPPartner (Attorney)OngoingReal estate, commercial and personal injury practice; Maui-based legal expertise
State of Hawaii House of RepresentativesLegislator1978–1982Public sector governance experience
Maui Health Systems (not-for-profit)Board Member1994–presentCommunity healthcare oversight; board service

External Roles

OrganizationRoleTenureNotes
Maui Arts & Cultural Center (non-profit)Board/Community ServiceNot disclosedCommunity engagement (dates not specified)
Other non-profit boards (various)Board/Community ServiceNot disclosedActive local service; details not itemized

Board Governance

  • Committee assignments: Audit Committee member; Nominating & Corporate Governance Committee Chair .
  • Audit Committee expertise: Board determined all Audit Committee members (including Takitani) are “audit committee financial experts” under SEC rules; all are independent under NYSE/SEC standards .
  • Independence status: Board determined each director (including Takitani) is independent .
  • Attendance and engagement: In FY2024, Board met 4 times; Audit 6; Compensation 2; Nominating 1; all directors attended 100% of Board/committee meetings. In FY2023, Board met 4; Audit 5; Compensation 4; Nominating 2; all directors attended 100% .
  • Board leadership: Roles of Chair and CEO are separated; no lead independent director currently, with independent oversight maintained .
  • Related-party transactions: None requiring disclosure since January 1, 2024 .
Attendance & MeetingsFY2023FY2024
Board meetings held4 4
Audit Committee meetings5 6
Compensation Committee meetings4 2
Nominating & Governance Committee meetings2 1
Director attendance rate100% 100%

Fixed Compensation

ComponentFY2023FY2024
Annual cash retainer ($)$44,967 $40,000
Meeting feesNone (not paid for attendance) None stated (structure unchanged)

Notes:

  • Committee service fees: MLP does not pay incremental fees for committee service, but in 2024 granted stock options to non-employee directors (other than Mr. Case) in connection with committee service under the 2017 Plan .

Performance Compensation

Equity AwardGrant detailsVestingValue/strike
Restricted stock (director annual grant, 2024)5,600 shares (to each of Ota, Sabin, Takitani, Aeppel, Ngo) Quarterly; 3,124 vested at 12/31/2024; remaining through 12/31/2025 Aggregate grant-date fair value $120,000 for Takitani
Stock options (director options, 2024)Options granted in 2024, vest quarterly Quarterly vesting; unvested 17,375; unexercised 69,500 (as of 12/31/2024, per director table) Company-wide 2024 director option grants: 385,500 shares across six directors at $22.25 strike (May 2024)
Total 2024 director equity (Tak)RS + optionsAs aboveRS $120,000; options grant-date fair value $616,312

Compensation structure signals:

  • In 2025, Compensation Committee will eliminate use of options and replace with restricted stock due to more certain valuation—applies to both directors and NEOs per committee mandate .
  • Clawback: 2017 Plan equity awards subject to clawback or recoupment per Board policy or law .
  • Option repricing prohibited without stockholder approval under the 2017 Plan .

Other Directorships & Interlocks

Company/OrganizationPublic company?RolePotential interlock/conflict
Maui Health SystemsNoBoard MemberHealthcare non-profit; no disclosed related-party transactions
Various Maui non-profitsNoBoard/Community rolesCommunity service; no conflicts disclosed
  • No public company directorships disclosed for Takitani in the last five years .
  • Largest shareholder pledging: Steve Case has pledged 5,993,750 shares to Bank of Hawaii and 3,000,000 to First Hawaiian Bank—board-level red flag but not attributed to Takitani; requires ongoing oversight .

Expertise & Qualifications

  • Legal expertise: Longstanding Maui-based attorney; partner in real estate/commercial law firm .
  • Legislative experience: Former Hawaii state legislator (1978–1982) .
  • Community leadership: Extensive Maui non-profit board involvement; long-term Maui Health Systems board member since 1994 .
  • Audit oversight credentials: Board determined Audit Committee members (including Takitani) meet SEC “financial expert” criteria .

Equity Ownership

MetricAs of Mar 21, 2024As of Mar 27, 2025
Beneficial ownership (shares)52,788 176,889
Ownership % of outstanding<1% <1%
Unvested restricted shares (director 2024 grant)2,476 remaining unvested (5,600 granted; 3,124 vested) N/A at record date; vesting continues through 12/31/2025
Options outstanding (director)Unvested 17,375; unexercised 69,500 Unvested/unexercised status per 2024 year-end; strike $22.25 for May 2024 cohort
Hedging/PledgingCompany policy prohibits hedging and pledging by insiders; Audit Committee may grant case-by-case exceptions for pledges Same; amended policy dated March 4, 2025

Insider Trades and Compliance

ItemYearDetail
Section 16(a) delinquencies (Form 4)2023/2024Forms 4 for multiple directors—including Anthony P. Takitani—for stock issued (May 16, 2023) and stock options granted (May 16, 2023) were reported late
Section 16(a) delinquencies (Form 4)2025Delinquencies disclosed only for CFO Wade K. Kodama (June 28, 2024 disposition) and CEO Race A. Randle (Jan 1, 2024 option grant); none for Takitani

Governance Assessment

  • Strengths: Independent director; chairs Nominating & Governance; Audit Committee financial expert; 100% attendance; no related-party transactions disclosed; robust clawback and anti-repricing provisions; insider trading policy prohibits hedging/pledging .
  • Alignment: Significant increase in beneficial ownership from 52,788 (2024) to 176,889 (2025), plus ongoing restricted stock and options exposure; equity vests over time, supporting alignment .
  • Areas to monitor (RED FLAGS): Prior Section 16 reporting delinquencies in 2023 (administrative control weakness); systemic board-level risk from largest shareholder share pledges (not associated with Takitani but relevant for governance) .
  • Compensation structure evolution: Movement away from options toward restricted stock in 2025 improves valuation certainty and reduces headline risk; ensure director equity mix remains appropriately at-risk and not overly guaranteed .